Concepedia

Hootan Khatami

HK

Statistics

Publications

2

Citations

1.1K

H-Index

2

Active since

2006

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Hootan Khatami is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in antidiabetic drug therapy, pharmacology, and clinical pharmacology.

Publications per year

2006–2007

2

Publications

2

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus

Itamar Raz, M Hanefeld, Lei Xu et al. · Diabetologia · 2006 · 617 citations · Full text

, , +13

Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin

Kjeld Hermansen, Mark Kipnes, Edmund Luo et al. · Diabetes Obesity and Metabolism · 2007 · 526 citations · Full text

, , +17

1–2 of 2